ARTELO BIOSCIENCES, INC. Accounts Payable and Accrued Liabilities, Current
ARTELO BIOSCIENCES, INC. (ARTL) had Accounts Payable and Accrued Liabilities, Current of $1.30 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent · last filed 2026-08-12
- 2026-06-30: Accounts Payable and Accrued Liabilities, Current $1.30M.
- 2026-03-31: Accounts Payable and Accrued Liabilities, Current $4.04M.
- 2025-12-31: Accounts Payable and Accrued Liabilities, Current $3.04M.
- 2025-09-30: Accounts Payable and Accrued Liabilities, Current $3.87M.
| Period end | Accounts Payable and Accrued Liabilities, Current | Accounts Payable and Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.30M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $4.04M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $3.04M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $3.87M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $4.84M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $2.51M 8-K · filed 2025-07-11 | |
| 2024-12-31 | $1.68M 8-K · filed 2026-03-17 | $1.68M 10-K · filed 2025-03-03 |
| 2024-09-30 | $627.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $863.00K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $607.00K 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $1.24M 8-K · filed 2025-07-11 | |
| 2023-09-30 | $840.00K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $523.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $701.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $905.00K 10-K · filed 2024-03-25 | |
| 2022-09-30 | $411.00K 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $432.00K 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $800.00K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $975.00K 10-K · filed 2023-03-31 | |
| 2021-11-30 | $590.00K 10-Q · filed 2022-01-12 | |
| 2021-08-31 | $471.00K 10-K · filed 2023-03-31 | $493.00K 10-K · filed 2021-11-29 |
| 2020-08-31 | $489.00K 10-KT · filed 2022-03-21 | $490.22K 10-K · filed 2020-11-04 |
| 2019-08-31 | $348.86K 10-K · filed 2020-11-04 | |
| 2019-05-31 | $912.41K 10-Q · filed 2019-07-15 | |
| 2019-02-28 | $586.00K 10-Q · filed 2019-04-15 | |
| 2018-11-30 | $634.70K 10-Q · filed 2019-01-14 | |
| 2018-08-31 | $529.27K 10-K/A · filed 2019-12-18 | |
| 2018-05-31 | $489.63K 10-Q · filed 2018-07-13 | |
| 2018-02-28 | $324.32K 10-Q/A · filed 2018-05-14 | $154.21K 10-Q · filed 2018-04-16 |
| 2017-11-30 | $133.97K 10-Q/A · filed 2018-03-21 | |
| 2017-08-31 | $28.58K 10-K · filed 2018-11-29 | |
| 2017-05-31 | $71.31K 10-Q · filed 2017-07-21 | |
| 2017-02-28 | $2.41K 10-Q · filed 2017-04-14 | |
| 2016-11-30 | $10.05K 10-Q · filed 2017-01-10 | |
| 2016-08-31 | $12.94K 10-K · filed 2017-11-29 | |
| 2016-05-31 | $8.61K 10-Q · filed 2016-07-05 | |
| 2016-02-29 | $7.41K 10-Q · filed 2016-04-01 | |
| 2015-11-30 | $2.70K 10-Q · filed 2016-01-14 | |
| 2015-08-31 | $1.74K 10-K · filed 2016-11-29 | |
| 2015-02-28 | $1.50K 10-Q · filed 2015-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |